Dr Emilie Gérard, medical oncologist at the Saint-André University hospital of Bordeaux, France presented the results from the French study TOSCA, evaluating cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas.
With the educational support of:
 |
 |
 |
 |